

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | homocysteine metabolic process (GO:0050667) | 6.08456685 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.85452400 |
| 3 | formation of translation preinitiation complex (GO:0001731) | 5.63860464 |
| 4 | L-serine metabolic process (GO:0006563) | 5.52784573 |
| 5 | pteridine-containing compound biosynthetic process (GO:0042559) | 5.20685083 |
| 6 | DNA unwinding involved in DNA replication (GO:0006268) | 5.04321870 |
| 7 | proteasome assembly (GO:0043248) | 5.01672595 |
| 8 | mitochondrial RNA metabolic process (GO:0000959) | 4.87915450 |
| 9 | purine nucleotide salvage (GO:0032261) | 4.87092731 |
| 10 | regulation of plasminogen activation (GO:0010755) | 4.74689027 |
| 11 | nucleobase biosynthetic process (GO:0046112) | 4.65343170 |
| 12 | IMP biosynthetic process (GO:0006188) | 4.64840278 |
| 13 | viral transcription (GO:0019083) | 4.63268479 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 4.59068989 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 4.58980811 |
| 16 | translational termination (GO:0006415) | 4.51110411 |
| 17 | CENP-A containing nucleosome assembly (GO:0034080) | 4.48765001 |
| 18 | chromatin remodeling at centromere (GO:0031055) | 4.44142446 |
| 19 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.39128140 |
| 20 | translational elongation (GO:0006414) | 4.37866881 |
| 21 | Golgi transport vesicle coating (GO:0048200) | 4.29878551 |
| 22 | COPI coating of Golgi vesicle (GO:0048205) | 4.29878551 |
| 23 | adenosine metabolic process (GO:0046085) | 4.29580687 |
| 24 | purine nucleobase biosynthetic process (GO:0009113) | 4.27030725 |
| 25 | serine family amino acid biosynthetic process (GO:0009070) | 4.20816904 |
| 26 | rRNA modification (GO:0000154) | 4.18627637 |
| 27 | DNA ligation (GO:0006266) | 4.16193672 |
| 28 | cysteine metabolic process (GO:0006534) | 4.14112499 |
| 29 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.11219102 |
| 30 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.09368304 |
| 31 | translational initiation (GO:0006413) | 4.03157700 |
| 32 | tetrahydrofolate metabolic process (GO:0046653) | 4.00428479 |
| 33 | cotranslational protein targeting to membrane (GO:0006613) | 3.97193535 |
| 34 | protein targeting to ER (GO:0045047) | 3.95632263 |
| 35 | IMP metabolic process (GO:0046040) | 3.95158501 |
| 36 | DNA strand elongation (GO:0022616) | 3.94657970 |
| 37 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.89738689 |
| 38 | rRNA methylation (GO:0031167) | 3.87319483 |
| 39 | protein localization to kinetochore (GO:0034501) | 3.82152090 |
| 40 | pseudouridine synthesis (GO:0001522) | 3.82085042 |
| 41 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.75990237 |
| 42 | protein localization to endoplasmic reticulum (GO:0070972) | 3.73021046 |
| 43 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.72894464 |
| 44 | cullin deneddylation (GO:0010388) | 3.68999725 |
| 45 | cellular protein complex disassembly (GO:0043624) | 3.68926238 |
| 46 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.68819091 |
| 47 | DNA replication initiation (GO:0006270) | 3.66085027 |
| 48 | folic acid-containing compound metabolic process (GO:0006760) | 3.64829650 |
| 49 | mitotic nuclear envelope disassembly (GO:0007077) | 3.63941052 |
| 50 | viral life cycle (GO:0019058) | 3.63063552 |
| 51 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.62946832 |
| 52 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.60819630 |
| 53 | histone exchange (GO:0043486) | 3.57414774 |
| 54 | ribosomal small subunit biogenesis (GO:0042274) | 3.57249559 |
| 55 | regulation of translational fidelity (GO:0006450) | 3.56749756 |
| 56 | galactose catabolic process (GO:0019388) | 3.56364104 |
| 57 | ribosomal large subunit biogenesis (GO:0042273) | 3.53897135 |
| 58 | tRNA aminoacylation for protein translation (GO:0006418) | 3.52150938 |
| 59 | negative regulation of RNA splicing (GO:0033119) | 3.50186874 |
| 60 | protein deneddylation (GO:0000338) | 3.49892946 |
| 61 | tRNA aminoacylation (GO:0043039) | 3.46240905 |
| 62 | amino acid activation (GO:0043038) | 3.46240905 |
| 63 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.46084067 |
| 64 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.46023267 |
| 65 | NADH dehydrogenase complex assembly (GO:0010257) | 3.46023267 |
| 66 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.46023267 |
| 67 | ribosome biogenesis (GO:0042254) | 3.45255862 |
| 68 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.45230528 |
| 69 | protein complex disassembly (GO:0043241) | 3.44880336 |
| 70 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.42674723 |
| 71 | DNA replication-independent nucleosome organization (GO:0034724) | 3.42674723 |
| 72 | protein-cofactor linkage (GO:0018065) | 3.42336566 |
| 73 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.42165668 |
| 74 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.41111426 |
| 75 | nuclear envelope disassembly (GO:0051081) | 3.40217409 |
| 76 | membrane disassembly (GO:0030397) | 3.40217409 |
| 77 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.38232987 |
| 78 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.38232987 |
| 79 | inner mitochondrial membrane organization (GO:0007007) | 3.33486917 |
| 80 | macromolecular complex disassembly (GO:0032984) | 3.27989605 |
| 81 | de novo posttranslational protein folding (GO:0051084) | 3.27315594 |
| 82 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.26940375 |
| 83 | postreplication repair (GO:0006301) | 3.25875528 |
| 84 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.25782370 |
| 85 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.25782370 |
| 86 | de novo protein folding (GO:0006458) | 3.25309946 |
| 87 | tRNA modification (GO:0006400) | 3.24802095 |
| 88 | establishment of integrated proviral latency (GO:0075713) | 3.24589205 |
| 89 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.24292755 |
| 90 | pteridine-containing compound metabolic process (GO:0042558) | 3.21393372 |
| 91 | sulfur amino acid biosynthetic process (GO:0000097) | 3.20725839 |
| 92 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.20335132 |
| 93 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.20057422 |
| 94 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.19378436 |
| 95 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.18792787 |
| 96 | spliceosomal snRNP assembly (GO:0000387) | 3.16635899 |
| 97 | translation (GO:0006412) | 3.15647161 |
| 98 | GMP metabolic process (GO:0046037) | 3.13334283 |
| 99 | histone arginine methylation (GO:0034969) | 3.12851114 |
| 100 | DNA duplex unwinding (GO:0032508) | 3.12726923 |
| 101 | protein complex biogenesis (GO:0070271) | 3.11645882 |
| 102 | negative regulation of ligase activity (GO:0051352) | 3.10030177 |
| 103 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.10030177 |
| 104 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.09960749 |
| 105 | telomere maintenance via recombination (GO:0000722) | 3.08763546 |
| 106 | DNA geometric change (GO:0032392) | 3.08756453 |
| 107 | microtubule nucleation (GO:0007020) | 3.07756803 |
| 108 | DNA replication checkpoint (GO:0000076) | 3.06492481 |
| 109 | telomere maintenance via telomere lengthening (GO:0010833) | 3.04769938 |
| 110 | viral mRNA export from host cell nucleus (GO:0046784) | 3.04756530 |
| 111 | transcription from mitochondrial promoter (GO:0006390) | 3.04610286 |
| 112 | establishment of viral latency (GO:0019043) | 3.04551868 |
| 113 | COPII vesicle coating (GO:0048208) | 3.04094590 |
| 114 | positive regulation of ligase activity (GO:0051351) | 3.02440245 |
| 115 | mRNA catabolic process (GO:0006402) | 3.01979926 |
| 116 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.00272077 |
| 117 | desmosome organization (GO:0002934) | 2.99976183 |
| 118 | regulation of translational termination (GO:0006449) | 2.99903576 |
| 119 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.99237291 |
| 120 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.98849684 |
| 121 | mRNA splicing, via spliceosome (GO:0000398) | 2.98849684 |
| 122 | mitotic recombination (GO:0006312) | 2.97679220 |
| 123 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.95616753 |
| 124 | rRNA processing (GO:0006364) | 2.95506087 |
| 125 | histone H2A acetylation (GO:0043968) | 2.95449257 |
| 126 | chaperone-mediated protein transport (GO:0072321) | 2.95370179 |
| 127 | respiratory chain complex IV assembly (GO:0008535) | 2.95242522 |
| 128 | RNA splicing, via transesterification reactions (GO:0000375) | 2.94702998 |
| 129 | nucleotide salvage (GO:0043173) | 2.94676055 |
| 130 | RNA catabolic process (GO:0006401) | 2.94650712 |
| 131 | peptidyl-arginine methylation (GO:0018216) | 2.93990429 |
| 132 | peptidyl-arginine N-methylation (GO:0035246) | 2.93990429 |
| 133 | galactose metabolic process (GO:0006012) | 2.93825848 |
| 134 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.92731529 |
| 135 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.91930602 |
| 136 | maturation of 5.8S rRNA (GO:0000460) | 2.91783351 |
| 137 | glycoside metabolic process (GO:0016137) | 2.90199715 |
| 138 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.89706916 |
| 139 | negative regulation of telomerase activity (GO:0051974) | 2.89228131 |
| 140 | platelet dense granule organization (GO:0060155) | 2.88631922 |
| 141 | purine-containing compound salvage (GO:0043101) | 2.88200678 |
| 142 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.87565967 |
| 143 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.86548178 |
| 144 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.86548178 |
| 145 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.86535649 |
| 146 | regulation of protein heterodimerization activity (GO:0043497) | 2.85035416 |
| 147 | non-recombinational repair (GO:0000726) | 2.84953604 |
| 148 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.84953604 |
| 149 | regulation of vitamin metabolic process (GO:0030656) | 2.83150519 |
| 150 | ribosome assembly (GO:0042255) | 2.82949651 |
| 151 | rRNA metabolic process (GO:0016072) | 2.82696490 |
| 152 | mitotic sister chromatid segregation (GO:0000070) | 2.82670439 |
| 153 | translesion synthesis (GO:0019985) | 2.81694349 |
| 154 | polyamine biosynthetic process (GO:0006596) | 2.81532939 |
| 155 | kinetochore assembly (GO:0051382) | 2.80697105 |
| 156 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.80226361 |
| 157 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.79589508 |
| 158 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.79589508 |
| 159 | regulation of ligase activity (GO:0051340) | 2.79552225 |
| 160 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.79335726 |
| 161 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.79335726 |
| 162 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.79335726 |
| 163 | mitotic metaphase plate congression (GO:0007080) | 2.77766240 |
| 164 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.77630168 |
| 165 | protein localization to chromosome, centromeric region (GO:0071459) | 2.77403298 |
| 166 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.77103811 |
| 167 | DNA double-strand break processing (GO:0000729) | 2.76029126 |
| 168 | protein complex localization (GO:0031503) | 2.75919482 |
| 169 | protein targeting to mitochondrion (GO:0006626) | 2.73393197 |
| 170 | white fat cell differentiation (GO:0050872) | 2.73240946 |
| 171 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.71557364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 6.98203127 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.79038022 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.41358532 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.25670881 |
| 5 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.99897388 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.95339325 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.91301373 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.86107578 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.77422643 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.76413080 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.76145911 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.75279995 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.74288959 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.73622032 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.71219136 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.64334847 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.55502033 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.49489071 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.47691794 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.46500962 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.44330616 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.43815657 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.35226364 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.10137590 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.08272612 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.05792299 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.05740936 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.02932355 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.98209828 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.97401496 |
| 31 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.96791432 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.94706097 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.94504366 |
| 34 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92605810 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91136533 |
| 36 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.83102634 |
| 37 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.79568792 |
| 38 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.78344544 |
| 39 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.77918254 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75999190 |
| 41 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.74813413 |
| 42 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.73663839 |
| 43 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69566684 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.69004320 |
| 45 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.66762075 |
| 46 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64978282 |
| 47 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.64938847 |
| 48 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.64436945 |
| 49 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.63831948 |
| 50 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.61733501 |
| 51 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.58759090 |
| 52 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.57197182 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57038621 |
| 54 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55663064 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.55443858 |
| 56 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.49002824 |
| 57 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.48704747 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48450881 |
| 59 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.47821618 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47285834 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.45557180 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44480757 |
| 63 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.42648645 |
| 64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.42004872 |
| 65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.38516271 |
| 66 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.38189535 |
| 67 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.37251205 |
| 68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.36693626 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.35139904 |
| 70 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.31910347 |
| 71 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27794894 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26613843 |
| 73 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23339922 |
| 74 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.22943502 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.20596629 |
| 76 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.20455420 |
| 77 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.16881494 |
| 78 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16822313 |
| 79 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.16744468 |
| 80 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15895007 |
| 81 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.14277451 |
| 82 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.12611489 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11640809 |
| 84 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.11184793 |
| 85 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.08668812 |
| 86 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08509025 |
| 87 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08479962 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08433814 |
| 89 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04447588 |
| 90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.03917295 |
| 91 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.01918938 |
| 92 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01822194 |
| 93 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01498438 |
| 94 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01052892 |
| 95 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.98181408 |
| 96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98053774 |
| 97 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.97996290 |
| 98 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.96905210 |
| 99 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.96002773 |
| 100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94836631 |
| 101 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94803777 |
| 102 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94006317 |
| 103 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.92661737 |
| 104 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.91729331 |
| 105 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.90263213 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89506498 |
| 107 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89357603 |
| 108 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.88173845 |
| 109 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.87539711 |
| 110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86918728 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86448223 |
| 112 | VDR_22108803_ChIP-Seq_LS180_Human | 0.85895096 |
| 113 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.85852409 |
| 114 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.85664650 |
| 115 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.82417499 |
| 116 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.82236722 |
| 117 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.79024277 |
| 118 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.78822345 |
| 119 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78677171 |
| 120 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.77894344 |
| 121 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75439864 |
| 122 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.73470519 |
| 123 | EWS_26573619_Chip-Seq_HEK293_Human | 0.64087146 |
| 124 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.63616589 |
| 125 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.61893088 |
| 126 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.61272177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.37765781 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.96692246 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.81532674 |
| 4 | MP0005360_urolithiasis | 3.81462281 |
| 5 | MP0003077_abnormal_cell_cycle | 3.53104452 |
| 6 | MP0002938_white_spotting | 3.48086022 |
| 7 | MP0008007_abnormal_cellular_replicative | 3.36803463 |
| 8 | MP0003111_abnormal_nucleus_morphology | 3.29612641 |
| 9 | MP0003123_paternal_imprinting | 3.29392121 |
| 10 | MP0002396_abnormal_hematopoietic_system | 3.22436293 |
| 11 | MP0008058_abnormal_DNA_repair | 2.74392675 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.61876003 |
| 13 | MP0008995_early_reproductive_senescence | 2.59363431 |
| 14 | MP0008057_abnormal_DNA_replication | 2.58735066 |
| 15 | MP0006054_spinal_hemorrhage | 2.57325623 |
| 16 | MP0004147_increased_porphyrin_level | 2.57175358 |
| 17 | MP0005670_abnormal_white_adipose | 2.56090938 |
| 18 | MP0009697_abnormal_copulation | 2.49303404 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 2.44009896 |
| 20 | MP0003941_abnormal_skin_development | 2.41632148 |
| 21 | MP0001730_embryonic_growth_arrest | 2.40660366 |
| 22 | MP0001661_extended_life_span | 2.29772311 |
| 23 | MP0005367_renal/urinary_system_phenotyp | 2.25020076 |
| 24 | MP0000516_abnormal_urinary_system | 2.25020076 |
| 25 | MP0008932_abnormal_embryonic_tissue | 2.17812086 |
| 26 | MP0000350_abnormal_cell_proliferation | 2.15554241 |
| 27 | MP0005646_abnormal_pituitary_gland | 2.15357327 |
| 28 | MP0003183_abnormal_peptide_metabolism | 2.13343765 |
| 29 | MP0000490_abnormal_crypts_of | 1.94541173 |
| 30 | MP0002736_abnormal_nociception_after | 1.92412376 |
| 31 | MP0000372_irregular_coat_pigmentation | 1.92401885 |
| 32 | MP0003718_maternal_effect | 1.91521584 |
| 33 | MP0001764_abnormal_homeostasis | 1.88024334 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.84854582 |
| 35 | MP0005332_abnormal_amino_acid | 1.83925585 |
| 36 | MP0003121_genomic_imprinting | 1.78034373 |
| 37 | MP0000537_abnormal_urethra_morphology | 1.75133649 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.71727719 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.68992720 |
| 40 | MP0001697_abnormal_embryo_size | 1.67091897 |
| 41 | MP0002080_prenatal_lethality | 1.65622734 |
| 42 | MP0003122_maternal_imprinting | 1.64007791 |
| 43 | MP0000647_abnormal_sebaceous_gland | 1.60768039 |
| 44 | MP0010307_abnormal_tumor_latency | 1.59631174 |
| 45 | MP0003984_embryonic_growth_retardation | 1.54113219 |
| 46 | MP0000313_abnormal_cell_death | 1.53661695 |
| 47 | MP0002019_abnormal_tumor_incidence | 1.52525439 |
| 48 | MP0002088_abnormal_embryonic_growth/wei | 1.52511960 |
| 49 | MP0002095_abnormal_skin_pigmentation | 1.52110558 |
| 50 | MP0001672_abnormal_embryogenesis/_devel | 1.51608416 |
| 51 | MP0005380_embryogenesis_phenotype | 1.51608416 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.50999256 |
| 53 | MP0002398_abnormal_bone_marrow | 1.45477129 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.43851596 |
| 55 | MP0000358_abnormal_cell_content/ | 1.43093591 |
| 56 | MP0003786_premature_aging | 1.39751120 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.38039669 |
| 58 | MP0010030_abnormal_orbit_morphology | 1.37511975 |
| 59 | MP0005171_absent_coat_pigmentation | 1.36499248 |
| 60 | MP0000703_abnormal_thymus_morphology | 1.36371965 |
| 61 | MP0001835_abnormal_antigen_presentation | 1.35183657 |
| 62 | MP0004197_abnormal_fetal_growth/weight/ | 1.33528968 |
| 63 | MP0003195_calcinosis | 1.32372065 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.31823927 |
| 65 | MP0005220_abnormal_exocrine_pancreas | 1.31440428 |
| 66 | MP0002254_reproductive_system_inflammat | 1.29369159 |
| 67 | MP0002722_abnormal_immune_system | 1.29226022 |
| 68 | MP0008877_abnormal_DNA_methylation | 1.29153056 |
| 69 | MP0004233_abnormal_muscle_weight | 1.28915682 |
| 70 | MP0000685_abnormal_immune_system | 1.28022559 |
| 71 | MP0001348_abnormal_lacrimal_gland | 1.27197325 |
| 72 | MP0001545_abnormal_hematopoietic_system | 1.24726691 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.24726691 |
| 74 | MP0002084_abnormal_developmental_patter | 1.24653689 |
| 75 | MP0008789_abnormal_olfactory_epithelium | 1.23966621 |
| 76 | MP0005408_hypopigmentation | 1.23030009 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 1.22974728 |
| 78 | MP0002102_abnormal_ear_morphology | 1.22478210 |
| 79 | MP0002085_abnormal_embryonic_tissue | 1.21581868 |
| 80 | MP0003890_abnormal_embryonic-extraembry | 1.20264074 |
| 81 | MP0002086_abnormal_extraembryonic_tissu | 1.18594768 |
| 82 | MP0002429_abnormal_blood_cell | 1.14958933 |
| 83 | MP0000858_altered_metastatic_potential | 1.09640111 |
| 84 | MP0006072_abnormal_retinal_apoptosis | 1.08445443 |
| 85 | MP0005076_abnormal_cell_differentiation | 1.06309999 |
| 86 | MP0000566_synostosis | 1.05991211 |
| 87 | MP0006292_abnormal_olfactory_placode | 1.03807950 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 1.02377578 |
| 89 | MP0008438_abnormal_cutaneous_collagen | 1.01252126 |
| 90 | MP0000371_diluted_coat_color | 1.00509095 |
| 91 | MP0000716_abnormal_immune_system | 0.99547241 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98600797 |
| 93 | MP0005384_cellular_phenotype | 0.97541927 |
| 94 | MP0001800_abnormal_humoral_immune | 0.96967201 |
| 95 | MP0002132_abnormal_respiratory_system | 0.96317875 |
| 96 | MP0005023_abnormal_wound_healing | 0.95960148 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 0.95572665 |
| 98 | MP0003943_abnormal_hepatobiliary_system | 0.95350333 |
| 99 | MP0009672_abnormal_birth_weight | 0.95281840 |
| 100 | MP0003866_abnormal_defecation | 0.93244503 |
| 101 | MP0002697_abnormal_eye_size | 0.92767218 |
| 102 | MP0003119_abnormal_digestive_system | 0.91812254 |
| 103 | MP0003283_abnormal_digestive_organ | 0.89809459 |
| 104 | MP0006036_abnormal_mitochondrial_physio | 0.89402436 |
| 105 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89229465 |
| 106 | MP0002452_abnormal_antigen_presenting | 0.89165677 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.88716009 |
| 108 | MP0005636_abnormal_mineral_homeostasis | 0.88640745 |
| 109 | MP0008872_abnormal_physiological_respon | 0.88025647 |
| 110 | MP0004264_abnormal_extraembryonic_tissu | 0.87950081 |
| 111 | MP0002420_abnormal_adaptive_immunity | 0.87628276 |
| 112 | MP0005394_taste/olfaction_phenotype | 0.86944639 |
| 113 | MP0005499_abnormal_olfactory_system | 0.86944639 |
| 114 | MP0001243_abnormal_dermal_layer | 0.86853842 |
| 115 | MP0001324_abnormal_eye_pigmentation | 0.86632729 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.86567257 |
| 117 | MP0003315_abnormal_perineum_morphology | 0.85477163 |
| 118 | MP0005085_abnormal_gallbladder_physiolo | 0.85409348 |
| 119 | MP0001819_abnormal_immune_cell | 0.84927744 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.84884714 |
| 121 | MP0001293_anophthalmia | 0.84584267 |
| 122 | MP0005621_abnormal_cell_physiology | 0.84380783 |
| 123 | MP0005084_abnormal_gallbladder_morpholo | 0.84177197 |
| 124 | MP0001849_ear_inflammation | 0.83155221 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.82081539 |
| 126 | MP0005253_abnormal_eye_physiology | 0.81232455 |
| 127 | MP0009053_abnormal_anal_canal | 0.80829795 |
| 128 | MP0000678_abnormal_parathyroid_gland | 0.79457644 |
| 129 | MP0004019_abnormal_vitamin_homeostasis | 0.78206492 |
| 130 | MP0006035_abnormal_mitochondrial_morpho | 0.78114422 |
| 131 | MP0003942_abnormal_urinary_system | 0.77436343 |
| 132 | MP0003186_abnormal_redox_activity | 0.77085544 |
| 133 | MP0004133_heterotaxia | 0.76313018 |
| 134 | MP0000653_abnormal_sex_gland | 0.76050610 |
| 135 | MP0001915_intracranial_hemorrhage | 0.75207188 |
| 136 | MP0001873_stomach_inflammation | 0.74121270 |
| 137 | MP0002751_abnormal_autonomic_nervous | 0.73853870 |
| 138 | MP0003937_abnormal_limbs/digits/tail_de | 0.72646398 |
| 139 | MP0000681_abnormal_thyroid_gland | 0.72438405 |
| 140 | MP0002111_abnormal_tail_morphology | 0.70951320 |
| 141 | MP0002166_altered_tumor_susceptibility | 0.70756713 |
| 142 | MP0005365_abnormal_bile_salt | 0.69541232 |
| 143 | MP0002090_abnormal_vision | 0.68936879 |
| 144 | MP0000579_abnormal_nail_morphology | 0.68647615 |
| 145 | MP0004885_abnormal_endolymph | 0.68135428 |
| 146 | MP0001119_abnormal_female_reproductive | 0.67377189 |
| 147 | MP0002282_abnormal_trachea_morphology | 0.66965382 |
| 148 | MP0002210_abnormal_sex_determination | 0.66864592 |
| 149 | MP0003724_increased_susceptibility_to | 0.66764326 |
| 150 | MP0001145_abnormal_male_reproductive | 0.66574909 |
| 151 | MP0009643_abnormal_urine_homeostasis | 0.65503506 |
| 152 | MP0005671_abnormal_response_to | 0.64812454 |
| 153 | MP0000598_abnormal_liver_morphology | 0.64742325 |
| 154 | MP0001186_pigmentation_phenotype | 0.64318255 |
| 155 | MP0005197_abnormal_uvea_morphology | 0.63212455 |
| 156 | MP0002075_abnormal_coat/hair_pigmentati | 0.62475100 |
| 157 | MP0005319_abnormal_enzyme/_coenzyme | 0.61852142 |
| 158 | MP0003115_abnormal_respiratory_system | 0.60514899 |
| 159 | MP0001666_abnormal_nutrient_absorption | 0.60486701 |
| 160 | MP0005395_other_phenotype | 0.60310199 |
| 161 | MP0000465_gastrointestinal_hemorrhage | 0.59916647 |
| 162 | MP0010155_abnormal_intestine_physiology | 0.59815007 |
| 163 | MP0009278_abnormal_bone_marrow | 0.58960126 |
| 164 | MP0002723_abnormal_immune_serum | 0.57876872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 6.70935472 |
| 2 | Abnormality of alanine metabolism (HP:0010916) | 6.70935472 |
| 3 | Hyperalaninemia (HP:0003348) | 6.70935472 |
| 4 | Abnormal umbilical cord blood vessels (HP:0011403) | 4.34957935 |
| 5 | Single umbilical artery (HP:0001195) | 4.34957935 |
| 6 | Abnormality of the fetal cardiovascular system (HP:0010948) | 4.34957935 |
| 7 | Colon cancer (HP:0003003) | 4.14293254 |
| 8 | Patchy hypopigmentation of hair (HP:0011365) | 4.04611847 |
| 9 | Abnormality of serum amino acid levels (HP:0003112) | 4.02818369 |
| 10 | White forelock (HP:0002211) | 4.00153021 |
| 11 | Degeneration of anterior horn cells (HP:0002398) | 3.95181411 |
| 12 | Abnormality of the anterior horn cell (HP:0006802) | 3.95181411 |
| 13 | Thrombocytosis (HP:0001894) | 3.90632453 |
| 14 | Aplastic anemia (HP:0001915) | 3.75222282 |
| 15 | Constricted visual fields (HP:0001133) | 3.69594083 |
| 16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.66973981 |
| 17 | Reticulocytopenia (HP:0001896) | 3.53469492 |
| 18 | Ependymoma (HP:0002888) | 3.52214135 |
| 19 | Abnormal number of erythroid precursors (HP:0012131) | 3.29474962 |
| 20 | Homocystinuria (HP:0002156) | 3.27920269 |
| 21 | Abnormality of homocysteine metabolism (HP:0010919) | 3.27920269 |
| 22 | Congenital sensorineural hearing impairment (HP:0008527) | 3.25335928 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.19911256 |
| 24 | Abnormality of the umbilical cord (HP:0010881) | 3.19867325 |
| 25 | Symptomatic seizures (HP:0011145) | 3.17811854 |
| 26 | Agnosia (HP:0010524) | 3.11293415 |
| 27 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.03211717 |
| 28 | Esophageal varix (HP:0002040) | 2.99062783 |
| 29 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.96731929 |
| 30 | Nausea (HP:0002018) | 2.94819704 |
| 31 | Hyperglycinemia (HP:0002154) | 2.93151037 |
| 32 | Generalized aminoaciduria (HP:0002909) | 2.91428737 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 2.85591850 |
| 34 | Birth length less than 3rd percentile (HP:0003561) | 2.83574441 |
| 35 | Medulloblastoma (HP:0002885) | 2.83455154 |
| 36 | Acute encephalopathy (HP:0006846) | 2.78972486 |
| 37 | Increased serum lactate (HP:0002151) | 2.68658972 |
| 38 | Selective tooth agenesis (HP:0001592) | 2.66903794 |
| 39 | 11 pairs of ribs (HP:0000878) | 2.64471096 |
| 40 | Lactic acidosis (HP:0003128) | 2.62022916 |
| 41 | Chromsome breakage (HP:0040012) | 2.60432832 |
| 42 | Acute necrotizing encephalopathy (HP:0006965) | 2.59633071 |
| 43 | Multiple enchondromatosis (HP:0005701) | 2.59320874 |
| 44 | IgM deficiency (HP:0002850) | 2.57998951 |
| 45 | Hepatocellular necrosis (HP:0001404) | 2.55114549 |
| 46 | Adenoma sebaceum (HP:0009720) | 2.53772353 |
| 47 | Angiofibromas (HP:0010615) | 2.53772353 |
| 48 | Cutaneous melanoma (HP:0012056) | 2.53209830 |
| 49 | Increased CSF lactate (HP:0002490) | 2.51664452 |
| 50 | Myocardial infarction (HP:0001658) | 2.49140674 |
| 51 | Abnormality of glycolysis (HP:0004366) | 2.48399647 |
| 52 | Increased serum pyruvate (HP:0003542) | 2.48399647 |
| 53 | Abnormal lung lobation (HP:0002101) | 2.46723003 |
| 54 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.45828794 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.45729686 |
| 56 | Cerebral edema (HP:0002181) | 2.43713851 |
| 57 | Amaurosis fugax (HP:0100576) | 2.43656659 |
| 58 | Neoplasm of the rectum (HP:0100743) | 2.43468584 |
| 59 | Hepatic necrosis (HP:0002605) | 2.43121889 |
| 60 | Basal cell carcinoma (HP:0002671) | 2.42598100 |
| 61 | Megaloblastic anemia (HP:0001889) | 2.41964072 |
| 62 | Methylmalonic acidemia (HP:0002912) | 2.41377855 |
| 63 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.41153620 |
| 64 | Mitochondrial inheritance (HP:0001427) | 2.40122662 |
| 65 | Oral leukoplakia (HP:0002745) | 2.40025818 |
| 66 | Stenosis of the external auditory canal (HP:0000402) | 2.38581823 |
| 67 | Rhabdomyosarcoma (HP:0002859) | 2.36489266 |
| 68 | Abnormality of the calcaneus (HP:0008364) | 2.36387021 |
| 69 | Hypoplasia of the pons (HP:0012110) | 2.36371721 |
| 70 | Spastic diplegia (HP:0001264) | 2.35346131 |
| 71 | Neoplasm of the pancreas (HP:0002894) | 2.32513899 |
| 72 | Carpal bone hypoplasia (HP:0001498) | 2.30827622 |
| 73 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.30432014 |
| 74 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.29267255 |
| 75 | Glossoptosis (HP:0000162) | 2.29261967 |
| 76 | Ovarian neoplasm (HP:0100615) | 2.28256351 |
| 77 | Deviation of the thumb (HP:0009603) | 2.27631427 |
| 78 | Meckel diverticulum (HP:0002245) | 2.27396081 |
| 79 | Type I transferrin isoform profile (HP:0003642) | 2.26565316 |
| 80 | Pallor (HP:0000980) | 2.25166242 |
| 81 | Anorexia (HP:0002039) | 2.23760546 |
| 82 | Freckling (HP:0001480) | 2.22225105 |
| 83 | Neoplasm of the colon (HP:0100273) | 2.22131603 |
| 84 | Neoplasm of the small intestine (HP:0100833) | 2.20811014 |
| 85 | Methylmalonic aciduria (HP:0012120) | 2.20674625 |
| 86 | Spinal muscular atrophy (HP:0007269) | 2.19982993 |
| 87 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.19617662 |
| 88 | Cerebral hypomyelination (HP:0006808) | 2.17666166 |
| 89 | Abnormality of the ileum (HP:0001549) | 2.14863359 |
| 90 | Intestinal polyposis (HP:0200008) | 2.13558437 |
| 91 | Spontaneous hematomas (HP:0007420) | 2.13038091 |
| 92 | Astrocytoma (HP:0009592) | 2.13030552 |
| 93 | Abnormality of the astrocytes (HP:0100707) | 2.13030552 |
| 94 | Rough bone trabeculation (HP:0100670) | 2.11748414 |
| 95 | Hypoglycemic seizures (HP:0002173) | 2.11298237 |
| 96 | Neoplasm of head and neck (HP:0012288) | 2.10788208 |
| 97 | Esophageal neoplasm (HP:0100751) | 2.10788208 |
| 98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.10139966 |
| 99 | Macrocytic anemia (HP:0001972) | 2.09159973 |
| 100 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.08886895 |
| 101 | Intestinal polyp (HP:0005266) | 2.07653177 |
| 102 | Limb-girdle muscle atrophy (HP:0003797) | 2.05948342 |
| 103 | Progressive macrocephaly (HP:0004481) | 2.05906046 |
| 104 | Trismus (HP:0000211) | 2.05704910 |
| 105 | Protrusio acetabuli (HP:0003179) | 2.05607420 |
| 106 | Hypoalphalipoproteinemia (HP:0003233) | 2.04374727 |
| 107 | Conjunctival telangiectasia (HP:0000524) | 2.03985204 |
| 108 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.03617063 |
| 109 | Abnormality of glycine metabolism (HP:0010895) | 2.03617063 |
| 110 | Poor speech (HP:0002465) | 2.03355601 |
| 111 | Heterochromia iridis (HP:0001100) | 2.03227122 |
| 112 | Proximal placement of thumb (HP:0009623) | 2.02869615 |
| 113 | Cervical subluxation (HP:0003308) | 2.02489079 |
| 114 | Hypoglycemic coma (HP:0001325) | 2.02349618 |
| 115 | Intrahepatic cholestasis (HP:0001406) | 2.02338250 |
| 116 | Abnormality of the preputium (HP:0100587) | 2.01628393 |
| 117 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.01627179 |
| 118 | Myelodysplasia (HP:0002863) | 1.99715918 |
| 119 | Hypolipoproteinemia (HP:0010981) | 1.97676120 |
| 120 | Cellular immunodeficiency (HP:0005374) | 1.95905841 |
| 121 | Lethargy (HP:0001254) | 1.95808809 |
| 122 | Tongue fasciculations (HP:0001308) | 1.94833161 |
| 123 | Metaphyseal cupping (HP:0003021) | 1.91510778 |
| 124 | Microretrognathia (HP:0000308) | 1.90645164 |
| 125 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.89782111 |
| 126 | Conjugated hyperbilirubinemia (HP:0002908) | 1.89669106 |
| 127 | Metabolic acidosis (HP:0001942) | 1.88954368 |
| 128 | Arteriovenous malformation (HP:0100026) | 1.87075371 |
| 129 | Missing ribs (HP:0000921) | 1.86512179 |
| 130 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.86468018 |
| 131 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.86468018 |
| 132 | Abnormal protein glycosylation (HP:0012346) | 1.86468018 |
| 133 | Abnormal glycosylation (HP:0012345) | 1.86468018 |
| 134 | Hand muscle atrophy (HP:0009130) | 1.86241061 |
| 135 | Increased density of long bones (HP:0006392) | 1.86071434 |
| 136 | Abnormality of chromosome stability (HP:0003220) | 1.84736780 |
| 137 | Papilloma (HP:0012740) | 1.84644375 |
| 138 | Verrucae (HP:0200043) | 1.84644375 |
| 139 | Increased hepatocellular lipid droplets (HP:0006565) | 1.83718720 |
| 140 | Proximal tubulopathy (HP:0000114) | 1.83441929 |
| 141 | Hyperglycemia (HP:0003074) | 1.82473982 |
| 142 | Oligomenorrhea (HP:0000876) | 1.81783202 |
| 143 | Large hands (HP:0001176) | 1.81762062 |
| 144 | Reduced antithrombin III activity (HP:0001976) | 1.81669765 |
| 145 | Intestinal atresia (HP:0011100) | 1.81582277 |
| 146 | Maternal diabetes (HP:0009800) | 1.81095485 |
| 147 | Premature ovarian failure (HP:0008209) | 1.80503766 |
| 148 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.80052691 |
| 149 | Premature graying of hair (HP:0002216) | 1.79843571 |
| 150 | Bowel diverticulosis (HP:0005222) | 1.79666597 |
| 151 | Lipid accumulation in hepatocytes (HP:0006561) | 1.78807513 |
| 152 | Shoulder girdle muscle weakness (HP:0003547) | 1.78267325 |
| 153 | Abnormality of the pons (HP:0007361) | 1.78060472 |
| 154 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77807340 |
| 155 | Patellar aplasia (HP:0006443) | 1.77744572 |
| 156 | Cortical visual impairment (HP:0100704) | 1.77642730 |
| 157 | Neoplasm of the adrenal gland (HP:0100631) | 1.77620422 |
| 158 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.77618778 |
| 159 | Slender long bone (HP:0003100) | 1.76681715 |
| 160 | Increased nuchal translucency (HP:0010880) | 1.76311131 |
| 161 | Postnatal microcephaly (HP:0005484) | 1.75835685 |
| 162 | Hyperphosphaturia (HP:0003109) | 1.75649464 |
| 163 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74537568 |
| 164 | Cortical dysplasia (HP:0002539) | 1.74503720 |
| 165 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.74463581 |
| 166 | Vertebral hypoplasia (HP:0008417) | 1.74463581 |
| 167 | Exercise intolerance (HP:0003546) | 1.74307573 |
| 168 | Supernumerary spleens (HP:0009799) | 1.74305593 |
| 169 | Biconcave vertebral bodies (HP:0004586) | 1.72812347 |
| 170 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.72682393 |
| 171 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.70728117 |
| 172 | Muscle fiber atrophy (HP:0100295) | 1.69856902 |
| 173 | Muscle fibrillation (HP:0010546) | 1.69366295 |
| 174 | Absent epiphyses (HP:0010577) | 1.68150703 |
| 175 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.68150703 |
| 176 | Abnormality of the labia minora (HP:0012880) | 1.66741685 |
| 177 | Ragged-red muscle fibers (HP:0003200) | 1.66726107 |
| 178 | CNS hypomyelination (HP:0003429) | 1.66481450 |
| 179 | Neuroblastoma (HP:0003006) | 1.66434469 |
| 180 | Primitive neuroectodermal tumor (HP:0030065) | 1.66434469 |
| 181 | Neuroblastic tumors (HP:0004376) | 1.66434469 |
| 182 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.66434469 |
| 183 | Cellulitis (HP:0100658) | 1.66208667 |
| 184 | Lymphopenia (HP:0001888) | 1.65159167 |
| 185 | High anterior hairline (HP:0009890) | 1.64891496 |
| 186 | Pancytopenia (HP:0001876) | 1.64316016 |
| 187 | Poikiloderma (HP:0001029) | 1.64230068 |
| 188 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.64132470 |
| 189 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.63228531 |
| 190 | Posterior subcapsular cataract (HP:0007787) | 1.62602329 |
| 191 | Biliary tract neoplasm (HP:0100574) | 1.61497319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 3.66082395 |
| 2 | TSSK6 | 3.65447322 |
| 3 | PBK | 3.20932956 |
| 4 | BUB1 | 3.20169519 |
| 5 | VRK2 | 3.04089681 |
| 6 | PASK | 3.02665917 |
| 7 | TGFBR1 | 2.86626336 |
| 8 | NEK1 | 2.83039747 |
| 9 | PKN2 | 2.75918129 |
| 10 | FLT3 | 2.53963083 |
| 11 | TRIM28 | 2.50970222 |
| 12 | WEE1 | 2.50649593 |
| 13 | CDC7 | 2.50321043 |
| 14 | BRSK2 | 2.32388526 |
| 15 | RPS6KB2 | 2.26335533 |
| 16 | ZAK | 2.23650159 |
| 17 | EIF2AK1 | 2.19918478 |
| 18 | PDK2 | 2.08871128 |
| 19 | TRIB3 | 2.08098718 |
| 20 | SCYL2 | 2.01475746 |
| 21 | NUAK1 | 1.92771974 |
| 22 | STK16 | 1.87546532 |
| 23 | EIF2AK3 | 1.87466500 |
| 24 | MAP4K1 | 1.79790392 |
| 25 | CCNB1 | 1.79645747 |
| 26 | MAP3K10 | 1.76949796 |
| 27 | PAK4 | 1.73618659 |
| 28 | BRSK1 | 1.70194333 |
| 29 | LRRK2 | 1.65519748 |
| 30 | ACVR1B | 1.65099734 |
| 31 | FGR | 1.63130776 |
| 32 | CDK9 | 1.59869872 |
| 33 | WNK3 | 1.57940422 |
| 34 | BCKDK | 1.57377058 |
| 35 | MAP4K2 | 1.54374754 |
| 36 | NEK2 | 1.50163332 |
| 37 | NME2 | 1.48850933 |
| 38 | DAPK1 | 1.46288044 |
| 39 | PLK4 | 1.42791498 |
| 40 | MAPKAPK3 | 1.38892107 |
| 41 | MKNK1 | 1.37396734 |
| 42 | BCR | 1.37008680 |
| 43 | ATR | 1.33669725 |
| 44 | TESK2 | 1.32567727 |
| 45 | TAF1 | 1.31765695 |
| 46 | NME1 | 1.23950289 |
| 47 | TESK1 | 1.23466117 |
| 48 | ERN1 | 1.23038842 |
| 49 | PLK3 | 1.22480172 |
| 50 | MAP3K12 | 1.21815214 |
| 51 | KIT | 1.21582602 |
| 52 | EPHB2 | 1.19676454 |
| 53 | MKNK2 | 1.17756050 |
| 54 | PLK1 | 1.17258691 |
| 55 | TLK1 | 1.16642933 |
| 56 | PIM2 | 1.16240623 |
| 57 | CDK8 | 1.10695205 |
| 58 | STK10 | 1.04053784 |
| 59 | SRPK1 | 1.03656113 |
| 60 | PLK2 | 1.03571041 |
| 61 | CSF1R | 1.02790166 |
| 62 | RPS6KA4 | 1.02724257 |
| 63 | ILK | 1.02299642 |
| 64 | CDK7 | 1.00146908 |
| 65 | VRK1 | 0.99464841 |
| 66 | INSRR | 0.98794816 |
| 67 | AURKB | 0.98093019 |
| 68 | CSNK1G3 | 0.95656578 |
| 69 | PDK4 | 0.95511471 |
| 70 | PDK3 | 0.95511471 |
| 71 | ZAP70 | 0.90484131 |
| 72 | CDK19 | 0.90482716 |
| 73 | BTK | 0.90282103 |
| 74 | CSNK1G1 | 0.89720190 |
| 75 | DYRK2 | 0.88920693 |
| 76 | GRK6 | 0.85982271 |
| 77 | EIF2AK2 | 0.83407566 |
| 78 | ERBB4 | 0.82426221 |
| 79 | MAP2K3 | 0.77669705 |
| 80 | MAP3K8 | 0.77217864 |
| 81 | CDK4 | 0.75051631 |
| 82 | TTK | 0.74933598 |
| 83 | AURKA | 0.73907049 |
| 84 | TIE1 | 0.72588223 |
| 85 | CHEK1 | 0.69110371 |
| 86 | BMPR1B | 0.68325762 |
| 87 | TNIK | 0.67492001 |
| 88 | CSNK1A1 | 0.62743516 |
| 89 | CSNK1A1L | 0.60700114 |
| 90 | SIK3 | 0.59634894 |
| 91 | MYLK | 0.59081644 |
| 92 | PIM1 | 0.58813902 |
| 93 | CSNK1G2 | 0.58595691 |
| 94 | PRKCI | 0.58508784 |
| 95 | JAK3 | 0.58159026 |
| 96 | TTN | 0.56804087 |
| 97 | CSNK2A2 | 0.54005782 |
| 98 | MATK | 0.53860316 |
| 99 | ERBB3 | 0.52734102 |
| 100 | ALK | 0.51396602 |
| 101 | STK24 | 0.50672916 |
| 102 | FGFR1 | 0.50264998 |
| 103 | PAK1 | 0.49949126 |
| 104 | LIMK1 | 0.49769931 |
| 105 | MST4 | 0.49094734 |
| 106 | STK4 | 0.48975614 |
| 107 | MAPKAPK5 | 0.48110800 |
| 108 | CDK2 | 0.45612425 |
| 109 | PAK2 | 0.44981356 |
| 110 | RPS6KB1 | 0.43775237 |
| 111 | CSNK2A1 | 0.43340567 |
| 112 | RPS6KA6 | 0.42369965 |
| 113 | RPS6KC1 | 0.41008721 |
| 114 | RPS6KL1 | 0.41008721 |
| 115 | ATM | 0.40815947 |
| 116 | MAPKAPK2 | 0.40394115 |
| 117 | BRD4 | 0.40019814 |
| 118 | RAF1 | 0.39967114 |
| 119 | SYK | 0.39504520 |
| 120 | MAP2K1 | 0.38499177 |
| 121 | CHEK2 | 0.38268754 |
| 122 | AKT2 | 0.38146968 |
| 123 | TGFBR2 | 0.37300504 |
| 124 | CAMKK2 | 0.36421470 |
| 125 | CLK1 | 0.36114895 |
| 126 | STK3 | 0.35463902 |
| 127 | TYK2 | 0.34885093 |
| 128 | DAPK3 | 0.33792181 |
| 129 | BLK | 0.32855835 |
| 130 | LMTK2 | 0.32465310 |
| 131 | MINK1 | 0.31298308 |
| 132 | MAP3K3 | 0.30681202 |
| 133 | CHUK | 0.29856782 |
| 134 | GRK1 | 0.29501727 |
| 135 | SMG1 | 0.29122227 |
| 136 | KDR | 0.27891670 |
| 137 | ABL2 | 0.27737567 |
| 138 | KSR1 | 0.27383806 |
| 139 | FGFR2 | 0.27365043 |
| 140 | CDK1 | 0.27279075 |
| 141 | EPHA2 | 0.27001659 |
| 142 | EGFR | 0.26995310 |
| 143 | OXSR1 | 0.26742885 |
| 144 | NEK6 | 0.26206567 |
| 145 | CAMK2D | 0.25935865 |
| 146 | PRKCE | 0.24851963 |
| 147 | SGK223 | 0.21938981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.33073173 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.79497315 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.62626851 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.58705188 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.55313490 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 3.09693881 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.96722980 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.95401233 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.87413332 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 2.87028299 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.74583449 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.51515609 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 2.27395927 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.25408089 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.20792655 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 2.20269042 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.10587527 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.00619811 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.92829942 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.86282044 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83947756 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.81521672 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.71998614 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.65703208 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.63142055 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.62795829 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.62712736 |
| 28 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.53162907 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.52827053 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.49890532 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46379341 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40991190 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.40207117 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30465105 |
| 35 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.29238723 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28336008 |
| 37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.28317603 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24474379 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.21920879 |
| 40 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.20504926 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14870333 |
| 42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14326346 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13212170 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11363578 |
| 45 | Protein export_Homo sapiens_hsa03060 | 1.07122245 |
| 46 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03070057 |
| 47 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.00003035 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98492279 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97594500 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96578702 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.95149426 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95147768 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 0.92471486 |
| 54 | Purine metabolism_Homo sapiens_hsa00230 | 0.91217990 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89804294 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89747270 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86161355 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85483228 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85241383 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.84882673 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83836547 |
| 62 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.83047686 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82751482 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82692558 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.82165045 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.81705424 |
| 67 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80687519 |
| 68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.76710901 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76643408 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76015911 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75530150 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73621743 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72266648 |
| 74 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.71672022 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71408485 |
| 76 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70696390 |
| 77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70329797 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68511415 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66145084 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65044343 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64912957 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.64013395 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63745723 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63449302 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63261841 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63086079 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61995507 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61413049 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58118320 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56389969 |
| 91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56005083 |
| 92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.55133494 |
| 93 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54927597 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.51418958 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50520095 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50032838 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47235090 |
| 98 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.46826334 |
| 99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44575426 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44112497 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43909745 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42400831 |
| 103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41012531 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.40913409 |
| 105 | Parkinsons disease_Homo sapiens_hsa05012 | 0.39721216 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39464291 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39339682 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39200873 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39033210 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39003384 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38282066 |
| 112 | Hepatitis B_Homo sapiens_hsa05161 | 0.36723247 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.35957101 |
| 114 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.35263498 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.35150113 |
| 116 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33985220 |
| 117 | Alcoholism_Homo sapiens_hsa05034 | 0.33614945 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33589534 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33553383 |
| 120 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33119031 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30999892 |
| 122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30682802 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30096468 |
| 124 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.28217143 |
| 125 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.27735922 |
| 126 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27358912 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25514395 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24659687 |
| 129 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23546766 |
| 130 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23057027 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.21572784 |
| 132 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.21253887 |
| 133 | Viral myocarditis_Homo sapiens_hsa05416 | 0.20564155 |
| 134 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19628361 |
| 135 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.18546970 |
| 136 | Other glycan degradation_Homo sapiens_hsa00511 | 0.17076911 |
| 137 | Endometrial cancer_Homo sapiens_hsa05213 | 0.16057464 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.15418932 |
| 139 | Huntingtons disease_Homo sapiens_hsa05016 | 0.13782374 |
| 140 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.12749630 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.10961423 |
| 142 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.10867595 |
| 143 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.10625154 |
| 144 | Leishmaniasis_Homo sapiens_hsa05140 | 0.10241950 |
| 145 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.08792119 |
| 146 | Pathways in cancer_Homo sapiens_hsa05200 | 0.05994295 |
| 147 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.05187677 |

